Send me a link:

*Text messaging rates may apply.

 Dow Down 0.72% Nasdaq Down 0.50%

Regeneron Pharmaceuticals, Inc. (REGN)

-NasdaqGS
303.09 Down 1.35(0.44%) Jul 25, 4:00PM EDT
|After Hours : 303.09 0.00 (0.00%) Jul 25, 4:48PM EDT
Prev Close:304.44
Open:303.46
Bid:301.02 x 100
Ask:305.00 x 100
1y Target Est:345.83
Beta:0.86
Next Earnings Date: 5-Aug-14REGN Earnings announcement
Day's Range:300.22 - 305.01
52wk Range:227.64 - 352.49
Volume:369,087
Avg Vol (3m):830,730
Market Cap:29.92B
P/E (ttm):86.90
EPS (ttm):3.49
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
REGNDown 0.44%29.92B
AMGNUp 0.47%92.99B
NVSDown 0.81%214.50B
RHHBYDown 0.90%250.67B

Key Statistics

Forward P/E (1 yr):25.07
P/S (ttm):13.12
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :9.91
Quarterly EPS Est (Jun-14) :2.28
Mean Recommendation*:2.1
PEG Ratio (5 yr expected):1.50

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Regeneron Pharmaceuticals, Inc., a biopharmaceutical company, discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions in the United States and internationally. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback